At Novartis, we know that our impact extends beyond the lives we touch with our medicines, and the performance we deliver for our stakeholders. We aim to have a positive impact on the communities in which we work, and build trust with society.
Our flagship Co-Creating Impact Summit on December 9, 2020, will provide an opportunity to build on the work we have already done in this area, and articulate the social, environmental and economic impact Novartis has on society, and on our planet.
With the rapidly changing ESG landscape, amplified by the COVID-19 pandemic, the upcoming Co-Creating Impact Summit combines external perspectives with thought leading practitioners and Novartis´ own impact valuation and materiality experiences.
If you are interested in long-term value creation, sustainability, stakeholder capitalism, ESG, non-financial disclosures and more register here for the Summit:
Download the Co-Creating Impact Summit agenda (PDF 0.2 MB)